Tower Research Capital LLC (TRC) - GT BIOPHARMA INC ownership

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of GT BIOPHARMA INC
ValueSharesWeighting
Q3 2023$4,858
-21.5%
20,158
+1.7%
0.00%
Q2 2023$6,185
+38556.2%
19,823
-30.2%
0.00%
-100.0%
Q1 2023$16
+14.3%
28,415
+84.2%
0.00%0.0%
Q4 2022$14
-99.8%
15,423
+187.0%
0.00%
Q3 2022$9,000
-18.2%
5,374
+45.6%
0.00%
Q2 2022$11,000
+22.2%
3,691
+14.2%
0.00%
Q1 2022$9,000
-25.0%
3,231
-16.9%
0.00%
Q4 2021$12,000
-47.8%
3,888
+13.9%
0.00%
-100.0%
Q3 2021$23,000
+475.0%
3,414
+1141.5%
0.00%
Q2 2021$4,000
-55.6%
275
-79.6%
0.00%
Q1 2021$9,0001,3500.00%
Other shareholders
GT BIOPHARMA INC shareholders Q4 2023
NameSharesValueWeighting ↓
Baskin Financial Services Inc. 151,354$470.01%
McCollum Christoferson Group LLC 17,500$5,4600.00%
Moss Adams Wealth Advisors LLC 10,000$3,1200.00%
JANE STREET GROUP, LLC 20,501$6,3960.00%
Cubist Systematic Strategies, LLC 10,458$3,2630.00%
Point72 Asset Management, L.P. 1$00.00%
UBS Group AG 3,033$9460.00%
Compagnie Lombard Odier SCmA 50,000$15,6000.00%
IFP Advisors, Inc 100$2750.00%
OSAIC HOLDINGS, INC. 1,017$3160.00%
View complete list of GT BIOPHARMA INC shareholders